Newswise — San Diego, CA, July 23, 2015 – Biomatrica, Inc. announced today the launch of DNAgard® Saliva HT, a new saliva DNA collection device optimized for use with automated laboratory DNA testing instruments.

Due to the non-invasive nature of saliva collection, this method of obtaining biological samples has become increasingly popular as an alternative to blood for performing laboratory genetic analysis. Saliva collection requires no needles and no trained medical personnel such as phlebotomists. It can be collected easily in decentralized locations, such as donors’ homes, and transported without the special precautions needed for other bodily fluids such as blood, urine and cerebral-spinal fluid.

According to Biomatrica Founder and Chief Operating Officer, Dr. Judy Muller-Cohn, “DNAgard Saliva® HT is unique in its laboratory friendly features, including a pierce-able cap that eliminates aerosol contamination and time-consuming uncapping for automated robotic sample processing. The device also features triple redundant labeling, which is LIMS compatible, to minimize the chance of samples being lost or misidentified.”

Additionally, Dr. Muller-Cohn noted that the device provided several donor-friendly features, such as a chemical stabilizer integrated into the device lid that is released into the saliva sample when donors screw on the lid. Also, the device has a wide funnel for easy saliva collection, a tethered cap to prevent cap loss and a wide base to prevent spills.

The company is now taking orders for DNAgard Saliva® HT, and the product will be available for shipment in early-to-mid-August 2015.

This product is For Research Use Only. Not for use in diagnostic procedures.

About Biomatrica, Inc.Biomatrica is a leading provider of innovative products for stabilizing biological samples and assays at ambient temperatures. Biomatrica's product range maintains the integrity of analytes from collection to detection in the diagnostics workflow. The company’s products have been adopted and validated by leading government forensic agencies, academic research institutions, global biobanks, molecular diagnostic companies, and laboratories around the world.